Publicaciones (65) Publicaciones de MARTA EUGENIA CUADROS CELORRIO

2024

  1. Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma

    Molecular Cancer

2023

  1. BCL7A is silenced by hypermethylation to promote acute myeloid leukemia

    Biomarker Research, Vol. 11, Núm. 1

  2. Benefits for cardiovascular system, bone density, and quality of life of a long-term hormone therapy in hysterectomized women: a 20-year follow-up study

    Menopause (New York, N.Y.), Vol. 30, Núm. 10, pp. 995-1001

  3. Clinical applications of DNA methylation profiling in lung cancer

    Translational Lung Cancer Research

2022

  1. Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers

    BMC medical genomics, Vol. 15, Núm. 1, pp. 45

  2. Gallic Acid: A Natural Phenolic Compound Exerting Antitumoral Activities in Colorectal Cancer via Interaction with G-Quadruplexes

    Cancers, Vol. 14, Núm. 11

  3. Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma

    Clinical Epigenetics, Vol. 14, Núm. 1

  4. Opportunities of miRNAs in cancer therapeutics

    MicroRNA in Human Malignancies (Elsevier), pp. 153-164

  5. PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer

    Cellular Oncology, Vol. 45, Núm. 2, pp. 323-332

  6. Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes

    Blood

2021

  1. ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project

    Blood Advances, Vol. 5, Núm. 3

  2. Erratum: Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment (Cell Chemical Biology (2021) 28(11) (1590–1601.e4), (S245194562100266X), (10.1016/j.chembiol.2021.05.021))

    Cell Chemical Biology

  3. Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment

    Cell Chemical Biology, Vol. 28, Núm. 11, pp. 1590-1601.e4

2020

  1. Comprehensive analysis of SWI/SNF inactivation in lung adenocarcinoma cell models

    Cancers, Vol. 12, Núm. 12, pp. 1-14

  2. Erratum: Preoperative chemoradiotherapy for rectal cancer: The sensitizer role of the association between miR-375 and c-Myc (Oncotarget (2017) 8 (82294-82302) DOI: 10.18632/oncotarget.19393)

    Oncotarget

  3. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL

    Leukemia, Vol. 34, Núm. 10, pp. 2722-2735

  4. LncRNA DLG2-AS1 as a novel biomarker in lung adenocarcinoma

    Cancers, Vol. 12, Núm. 8, pp. 1-10

  5. Lncrna-mrna co-expression analysis identifies al133346.1/ccn2 as biomarkers in pediatric b-cell acute lymphoblastic leukemia

    Cancers, Vol. 12, Núm. 12, pp. 1-15

  6. The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma

    Oncotarget, Vol. 11, Núm. 13, pp. 1172-1185

2019

  1. Correction to: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines (Clinical and Translational Oncology, (2017), 19, 8, (1010-1017), 10.1007/s12094-017-1633-2)

    Clinical and Translational Oncology